Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease.
Krassenburg LAP, Maan R, Puenpatom A, Erler NS, Welsch C, van Hees S, Cerrhoci O, Vermehren J, de Knegt RJ, Hansen BE, Zeuzem S, Vanwolleghem T, Janssen HLA, de Man RA, Feld JJ, van der Meer AJ. Krassenburg LAP, et al. Among authors: van hees s. BMJ Open Gastroenterol. 2023 Dec 7;10(1):e001209. doi: 10.1136/bmjgast-2023-001209. BMJ Open Gastroenterol. 2023. PMID: 38637963 Free PMC article.
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation.
Chi H, Wong D, Peng J, Cao J, Van Hees S, Vanwolleghem T, Qi X, Chen L, Feld JJ, de Knegt RJ, Hansen BE, Janssen HLA. Chi H, et al. Among authors: van hees s. Clin Infect Dis. 2017 Aug 15;65(4):680-683. doi: 10.1093/cid/cix353. Clin Infect Dis. 2017. PMID: 28575292
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Hirode G, Choi HSJ, Chen CH, Su TH, Seto WK, Van Hees S, Papatheodoridi M, Lens S, Wong G, Brakenhoff SM, Chien RN, Feld J, Sonneveld MJ, Chan HLY, Forns X, Papatheodoridis GV, Vanwolleghem T, Yuen MF, Hsu YC, Kao JH, Cornberg M, Hansen BE, Jeng WJ, Janssen HLA; RETRACT-B Study Group. Hirode G, et al. Among authors: van hees s. Gastroenterology. 2022 Mar;162(3):757-771.e4. doi: 10.1053/j.gastro.2021.11.002. Epub 2021 Nov 9. Gastroenterology. 2022. PMID: 34762906
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Hirode G, Hansen BE, Chen CH, Su TH, Wong G, Seto WK, Van Hees S, Papatheodoridi M, Brakenhoff SM, Lens S, Choi HSJ, Chien RN, Feld JJ, Forns X, Sonneveld MJ, Papatheodoridis GV, Vanwolleghem T, Yuen MF, Chan HLY, Kao JH, Hsu YC, Cornberg M, Jeng WJ, Janssen HLA; RETRACT-B study group. Hirode G, et al. Among authors: van hees s. Am J Gastroenterol. 2023 Sep 1;118(9):1601-1608. doi: 10.14309/ajg.0000000000002203. Epub 2023 Jan 30. Am J Gastroenterol. 2023. PMID: 36719174
Clinical management of chronic hepatitis B: A concise overview.
Furquim d'Almeida A, Ho E, Van Hees S, Vanwolleghem T. Furquim d'Almeida A, et al. Among authors: van hees s. United European Gastroenterol J. 2022 Feb;10(1):115-123. doi: 10.1002/ueg2.12176. Epub 2021 Nov 30. United European Gastroenterol J. 2022. PMID: 34846093 Free PMC article. Review.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Choi HSJ, Hirode G, Chen CH, Su TH, Seto WK, Van Hees S, Papatheodoridi M, Lens S, Wong GLH, Brakenhoff SM, Chien RN, Feld JJ, Sonneveld MJ, Chan HLY, Forns X, Papatheodoridis GV, Vanwolleghem T, Yuen MF, Hsu YC, Kao JH, Cornberg M, Hansen BE, Jeng WJ, Janssen HLA; RETRACT-B study group. Choi HSJ, et al. Among authors: van hees s. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1513-1522.e4. doi: 10.1016/j.cgh.2022.07.005. Epub 2022 Jul 19. Clin Gastroenterol Hepatol. 2023. PMID: 35863683 Free article.
Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue-induced HBeAg seroconversion.
Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen HLA, Vanwolleghem T. Van Hees S, et al. Among authors: van vlierberghe h. J Viral Hepat. 2019 Jun;26(6):766-769. doi: 10.1111/jvh.13084. Epub 2019 Mar 14. J Viral Hepat. 2019. PMID: 30801868 No abstract available.
71 results